At a glance
A cyclic heptapeptide analogue related to α-MSH, described in synthesis research and a small early human pilot.
Limits of the evidence. Three volunteers cannot establish general or long-term safety. Chemical synthesis does not demonstrate clinical suitability. Do not treat all melanocortin receptors as equivalent targets.
Identity and specifications
Melanotan II is a cyclic peptide. A name or intact mass alone may not resolve every structural or stereochemical question for cyclic material.
What the selected studies examined
Ryakhovsky and colleagues describe chemical synthesis. Dorr and colleagues report an early human pilot involving three volunteers. The synthesis study and exploratory clinical report have very different aims.
Limitations and open questions
Three volunteers cannot establish general or long-term safety. Chemical synthesis does not demonstrate clinical suitability. Do not treat all melanocortin receptors as equivalent targets.
These publications describe the materials and experimental conditions used by their authors. They do not establish the identity, composition, stability, safety or performance of East Coast Labs material. A reference list is a selected starting point, not a systematic review.
Interpreting a supplied material
Check the exact product and selected size, then read its documentation status. A laboratory report describes the named sample at the stated date; it does not establish a match to current stock. Read Testing & quality for the distinction between document authenticity and a documented lot relationship.
Handling, solvent compatibility and stability require material-specific information and a validated laboratory protocol. Published biological findings do not establish storage conditions or suitability for a particular experiment.
